Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections.

Labeaud AD, Bashir F, King CH.

Popul Health Metr. 2011 Jan 10;9(1):1. doi: 10.1186/1478-7954-9-1.

2.

Present and future arboviral threats.

Weaver SC, Reisen WK.

Antiviral Res. 2010 Feb;85(2):328-45. doi: 10.1016/j.antiviral.2009.10.008. Epub 2009 Oct 24. Review.

3.

Global burden of disease in young people aged 10-24 years: a systematic analysis.

Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, Sawyer SM, Mathers CD.

Lancet. 2011 Jun 18;377(9783):2093-102. doi: 10.1016/S0140-6736(11)60512-6. Epub 2011 Jun 7. Review. Erratum in: Lancet. 2011 Aug 6;378(9790):486.

PMID:
21652063
4.

Selected major risk factors and global and regional burden of disease.

Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group.

Lancet. 2002 Nov 2;360(9343):1347-60. Review.

PMID:
12423980
5.

Microbial agents associated with waterborne diseases.

Leclerc H, Schwartzbrod L, Dei-Cas E.

Crit Rev Microbiol. 2002;28(4):371-409. Review.

PMID:
12546197
6.

Neurologic Manifestation of Chikungunya Virus.

Brizzi K.

Curr Infect Dis Rep. 2017 Feb;19(2):6. doi: 10.1007/s11908-017-0561-1. Review.

PMID:
28233188
7.

The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.

Krishnamurthi RV, Moran AE, Forouzanfar MH, Bennett DA, Mensah GA, Lawes CM, Barker-Collo S, Connor M, Roth GA, Sacco R, Ezzati M, Naghavi M, Murray CJ, Feigin VL; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group.

Glob Heart. 2014 Mar;9(1):101-6. doi: 10.1016/j.gheart.2014.01.003. Review.

PMID:
25432119
8.

Emerging and re-emerging arboviral diseases in Southeast Asia.

Dash AP, Bhatia R, Sunyoto T, Mourya DT.

J Vector Borne Dis. 2013 Apr-Jun;50(2):77-84. Review.

10.

Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.

Mansfield KL, Banyard AC, McElhinney L, Johnson N, Horton DL, Hernández-Triana LM, Fooks AR.

Vaccine. 2015 Oct 13;33(42):5520-31. doi: 10.1016/j.vaccine.2015.08.020. Epub 2015 Aug 19. Review.

11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
12.

Vaccines and animal models for arboviral encephalitides.

Nalca A, Fellows PF, Whitehouse CA.

Antiviral Res. 2003 Nov;60(3):153-74. Review.

PMID:
14638392
13.

Systematic review of foodborne burden of disease studies: quality assessment of data and methodology.

Haagsma JA, Polinder S, Stein CE, Havelaar AH.

Int J Food Microbiol. 2013 Aug 16;166(1):34-47. doi: 10.1016/j.ijfoodmicro.2013.05.029. Epub 2013 Jun 13. Review.

PMID:
23827806
14.

Measuring the global burden of disease and epidemiological transitions: 2002-2030.

Lopez AD, Mathers CD.

Ann Trop Med Parasitol. 2006 Jul-Sep;100(5-6):481-99. Review.

PMID:
16899150
15.

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T.

Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Review.

PMID:
23993280
16.

Global burden of human food-borne trematodiasis: a systematic review and meta-analysis.

Fürst T, Keiser J, Utzinger J.

Lancet Infect Dis. 2012 Mar;12(3):210-21. doi: 10.1016/S1473-3099(11)70294-8. Epub 2011 Nov 20. Review.

PMID:
22108757

Supplemental Content

Support Center